Lemon Juice Mediated Reaction under Ultrasound Irradiation : Synthesis of Indolofuroquinoxalines as Potential Anticancer Agents

Copyright© Bentham Science Publishers; For any queries, please email at epubbenthamscience.net..

BACKGROUND: A non-hazardous synthetic methodology has been developed for the preparation of compounds based on indolofuroquinoxaline framework. Lemon juice that is known to play the role of a biocatalyst in various organic reactions was used for this purpose.

METHOD: A number of indolofuroquinoxaline derivatives were prepared via the lemon juice mediated condensation of methyl 2-(2-chloro-1H-indol-3-yl)-2-oxoacetate or its N-alkyl derivatives with 1,2- diamines under ultrasound irradiation. All the synthesized compounds were screened via an MTT assay for their potential anticancer properties in vitro using a number of cancer cell lines including MDA-MB 231, and MCF7, K562, Colo-205 and IMR-32 and the non-cancerous HEK293 cell line. Compounds 3a, 3b and 3c showed promising growth inhibition against K562, MDA-MB 231 and MCF7 cell lines but no significant effects on HEK293 cell line suggesting their selectivity towards cancer cells.

RESULTS AND CONCLUSION: Moreover, according to their IC50 values, all these compounds appeared to be relatively more potent towards K562 cell line over MDA-MB 231 and MCF7 cell lines indicating their potential against leukemia.

Medienart:

E-Artikel

Erscheinungsjahr:

2019

Erschienen:

2019

Enthalten in:

Zur Gesamtaufnahme - volume:19

Enthalten in:

Mini reviews in medicinal chemistry - 19(2019), 8 vom: 01., Seite 671-678

Sprache:

Englisch

Beteiligte Personen:

Prasanna, Gutta Lakshmi [VerfasserIn]
Rao, Bodapati Veera Durga [VerfasserIn]
Reddy, Alugubelli Gopi [VerfasserIn]
Rao, Mandava V Basaveswara [VerfasserIn]
Pal, Manojit [VerfasserIn]

Links:

Volltext

Themen:

Anticancer
Antineoplastic Agents
Antitumor
Indolofuroquinoxaline
Journal Article
Lemon juice
MCF7
Quinoxalines
Ultrasound.

Anmerkungen:

Date Completed 24.06.2019

Date Revised 24.06.2019

published: Print

Citation Status MEDLINE

doi:

10.2174/1389557518666181029100044

funding:

Förderinstitution / Projekttitel:

PPN (Katalog-ID):

NLM290048265